Pendapatan dodolan perusahaan certara.com (CERT)

Certara, Inc. (CERT) is a recognized global authority in biosimulation, providing solutions that are critical to medicine. The company's sales on this chart confirm high capital efficiency, with the current metric standing at 0.40. Its dominance is cemented by the FDA's use of the software, establishing the product as an industry standard. Widespread adoption among biopharma behemoths guarantees business stability and eliminates dependence on individual clients.

Certara Software (CERT): Dodolan perusahaan saka 04.07.2022 nganti 13.11.2026

Rincian analitis perusahaan Certara, Inc.

- rega lan prakiraan konsensus rega:

Rega saham Certara Software|CERT - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar Certara, Inc.|CERT - Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Nilai Buku saben Saham Certara|CERT - Aset Bersih Perusahaan|Nilai Pasar marang Nilai Buku certara.com|CERT - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

- data bathi resik lan rasio valuasi:

CERT - Bathi resik|Bathi resik sing dikarepake Certara, Inc.|CERT - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi certara.com|CERT - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Certara, Inc.|CERT - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Certara|CERT - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan certara.com|CERT - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Certara, Inc.

- rincian pendapatan lan dodolan emiten:

CERT - Pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Certara Software|CERT - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Certara, Inc.

Ringkesan analisis perusahaan:CERT Certara Software

This indicator determines the fundamental resilience of the business by analyzing daily revenue inflows. The sales dynamics of Certara, Inc. (CERT) allow for an assessment of real cash flow liquidity during periods of market volatility. The metric aggregates actual product sales revenue, reaching a current value of 0.40. For Certara, Inc. (CERT), such stability is ensured by its SaaS model and a diversified client portfolio, which minimizes the risks associated with the cyclical nature of the biotechnology sector.

Perusahaan pesaing